
Vicapsys Life Sciences, Inc. – OTC:VICP
Vicapsys Life Sciences stock price today
Vicapsys Life Sciences stock price monthly change
Vicapsys Life Sciences stock price quarterly change
Vicapsys Life Sciences stock price yearly change
Vicapsys Life Sciences key metrics
Market Cap | 224.49M |
Enterprise value | N/A |
P/E | -50 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | -59.94 |
PEG ratio | -0.55 |
EPS | -0.04 |
Revenue | N/A |
EBITDA | -721.90K |
Income | -1.42M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeVicapsys Life Sciences stock price history
Vicapsys Life Sciences stock forecast
Vicapsys Life Sciences financial statements
Dec 2022 | 0 | -832.83K | |
---|---|---|---|
Mar 2023 | 0 | -211.27K | |
Jun 2023 | 0 | -135.69K | |
Sep 2023 | 0 | -240.34K |
Dec 2022 | 72021 | 1.02M | 1420.16% |
---|---|---|---|
Mar 2023 | 63293 | 1.20M | 1903.31% |
Jun 2023 | 378147 | 1.47M | 389.18% |
Sep 2023 | 208486 | 1.54M | 739.79% |
Dec 2022 | 2.88K | 0 | -15.00K |
---|---|---|---|
Mar 2023 | -9.95K | 0 | 0 |
Jun 2023 | -218.10K | 0 | 445.24K |
Sep 2023 | -107.41K | 0 | -70.33K |
Vicapsys Life Sciences alternative data
Aug 2023 | 2 |
---|---|
Sep 2023 | 2 |
Oct 2023 | 2 |
Nov 2023 | 2 |
Dec 2023 | 2 |
Jan 2024 | 2 |
Feb 2024 | 2 |
Mar 2024 | 2 |
Apr 2024 | 2 |
May 2024 | 2 |
Jun 2024 | 2 |
Jul 2024 | 2 |
Vicapsys Life Sciences other data
Period | Buy | Sel |
---|---|---|
Jan 2010 | 0 | 5000 |
Aug 2010 | 0 | 20000 |
Sep 2010 | 0 | 5000 |
-
What's the price of Vicapsys Life Sciences stock today?
One share of Vicapsys Life Sciences stock can currently be purchased for approximately $1.77.
-
When is Vicapsys Life Sciences's next earnings date?
Unfortunately, Vicapsys Life Sciences's (VICP) next earnings date is currently unknown.
-
Does Vicapsys Life Sciences pay dividends?
No, Vicapsys Life Sciences does not pay dividends.
-
How much money does Vicapsys Life Sciences make?
Vicapsys Life Sciences has a market capitalization of 224.49M.
-
What is Vicapsys Life Sciences's stock symbol?
Vicapsys Life Sciences, Inc. is traded on the OTC under the ticker symbol "VICP".
-
What is Vicapsys Life Sciences's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Vicapsys Life Sciences?
Shares of Vicapsys Life Sciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Vicapsys Life Sciences have?
As Jul 2024, Vicapsys Life Sciences employs 2 workers.
-
When Vicapsys Life Sciences went public?
Vicapsys Life Sciences, Inc. is publicly traded company for more then 27 years since IPO on 23 Feb 1998.
-
What is Vicapsys Life Sciences's official website?
The official website for Vicapsys Life Sciences is vicapsys.com.
-
Where are Vicapsys Life Sciences's headquarters?
Vicapsys Life Sciences is headquartered at 1735 Buford Highway, Cumming, GA.
-
How can i contact Vicapsys Life Sciences?
Vicapsys Life Sciences's mailing address is 1735 Buford Highway, Cumming, GA and company can be reached via phone at +972 8918033.
Vicapsys Life Sciences company profile:

Vicapsys Life Sciences, Inc.
vicapsys.comOTC
2
Biotechnology
Healthcare
Vicapsys Life Sciences, Inc. focuses on the development and commercialization of VICAPSYN proprietary product. Its product is applied to transplantation therapies and related stem-cell applications in the transplantation field. The company is also developing VYBRIN, a product based on CXCL12 for prevention of post-surgical adhesions in abdominal surgery, coating of implantable medical devices and other implants to eliminate fibrosis, and wound healing with a focus on diabetic ulcers. The company was formerly known as Phage Therapeutics International, Inc. and changed its name to Vicapsys Life Sciences, Inc. in September 2017. Vicapsys Life Sciences, Inc. was incorporated in 1997 and is based in Suwanee, Georgia.
Cumming, GA 30024
CIK: 0001468639
ISIN: US92560A1060
CUSIP: 92560A106